Pulse BiosciencesPLSE +7.44%31 Days Payable is 682.90 as of Mar. 2026, which is 59% above its 10-year median of 428.52. GuruFocus rates PLSE with a GF Score™ of 31/100. The stock has 3 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Pulse Biosciences ranks better than 95.72% on this metric.
The historical rank and industry rank for Pulse Biosciences's Days Payable or its related term are showing as below:
PLSE'
s Days Payable Range Over the Past 10 Years
Min: 68.41 Med: 428.52 Max: 1506.73
Current: 1094.44
During the past 12 years, Pulse Biosciences's highest Days Payable was 1506.73. The lowest was 68.41. And the median was 428.52.
PLSE's Days Payable is ranked better than 95.72% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs PLSE: 1094.44
Pulse Biosciences's Days Payable
increased
from Mar. 2025 (0.00) to Mar. 2026 (682.90).
It may suggest that Pulse Biosciencesdelayed paying its suppliers.
Pulse Biosciences Days Payable Related Terms
Pulse Biosciences Days Payable Historical Data
* Premium members only.
The historical data trend for Pulse Biosciences's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Pulse Biosciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pulse Biosciences Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pulse Biosciences's Days Payable distribution charts can be found below:
* The bar in red indicates where Pulse Biosciences's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Pulse Biosciences's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pulse Biosciences (PLSE) has a Days Payable of 682.90 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Pulse Biosciences and its competitors. This is 59% above median its historical median of 428.52. Over the past decade, Pulse Biosciences' Days Payable has ranged from 68.41 to 1,506.73. According to the industry distribution chart, Pulse Biosciences ranks #34 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 4.3%.
Is Pulse Biosciences' Days Payable too high?
Pulse Biosciences' current Days Payable of 682.90 is 59% above median its 10-year median of 428.52. Over the past 10 years, this metric has ranged from a low of 68.41 to a high of 1,506.73. The Medical Devices & Instruments industry median Days Payable is 67.87. Pulse Biosciences' value of 682.90 is 906.2% above this industry median. Based on the distribution chart, Pulse Biosciences ranks #34 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Pulse Biosciences has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Pulse Biosciences' Days Payable compare to NNNN and STAA?
According to the Medical Devices & Instruments industry distribution chart, Pulse Biosciences ranks #34 out of 795 companies for Days Payable. This places Pulse Biosciences in the top 4% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.87. Pulse Biosciences' value of 682.90 is 906.2% above this benchmark. Historically, Pulse Biosciences' own Days Payable has ranged from 68.41 to 1,506.73 over the past decade. While the company's 10-year median is 428.52 vs. the industry median of 67.87, Pulse Biosciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pulse Biosciences's current Days Payable of 682.90 is 906.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Pulse Biosciences and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pulse Biosciences's current Days Payable is 682.90, which is 59% above median its own 10-year median of 428.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pulse Biosciences stock overvalued right now?
Pulse Biosciences (PLSE) has a current Days Payable of 682.90. The current Days Payable is 682.90, which is 59% above median its 10-year median of 428.52 and 906.2% above the Medical Devices & Instruments industry median of 67.87. Pulse Biosciences' overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Pulse Biosciences (PLSE), the current Days Payable is 682.90 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
31GF Score
Get the complete analysis for PLSE
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PLSE has been successfully added to your 
